FLT3 and acute myeloid leukemia: In conclusion, the results of this SLR and meta‐analysis of global FLT3 mutation frequency in patients with AML indicate a global population prevalence of 20% for FLT3‐ITD mutations and 7% for FLT3‐TKD.